Skip to content
Mass spectrometric analysis of lipids

New Unique LipidCreator

Dortmund, 16th June 2020

Science hast been increasingly using the many different functions of lipids in the human body to diagnose diseases earlier and to better predict their course. Although lipids have a big potential as biomarkers, their analysis has so far been technically complex. Therefore, researchers at the Leibniz Institute for Analytical Sciences (ISAS) and the Institute of Analytical Chemistry at the Universität Wien (University of Vienna) have developed the first software for targeted mass spectrometric analyses of lipids. "LipidCreator has a high clinical relevance. The software enables us to determine specific lipid groups and lipid signal molecules, which we have decoded using mass spectrometry, faster and more efficiently than before. This way, we gain insights into blood coagulation and the origin of thromboses, for example", explains Ass.-Prof. Dipl.-Biol. Robert Ahrends from the Universität Wien and former head of the "Lipidomics" research group at ISAS.

Various application areas and large lipid database

The new software, which the renowned journal "Nature Communications" has recently reported on, is an important step towards establishing the analysis of all lipids in a cell, tissue or organism. Not only does it enable new investigations in health research, but it is also suitable for various laboratory environments. At the same time LipidCreator serves as a huge library of lipid knowledge.

Lipids play an important role in health

Lipids are chemically very different, have a complex structure and consist of combinations of different building blocks such as sugars, fatty acyls and binding types. In public perception, they are often notorious as fats that make people ill and fat - although they play an important role in the human body. For life is enveloped in lipids, fats and waxes: they form cells and organelles, convey information, protect the organism from harsh environmental conditions and serve as energy building blocks.

The mass spectrometry required for LipidCreator has become both faster and more sensitive in recent years. Today, up to 500 lipids can be analyzed by mass spectrometer.

Read more about the LipidCreator in Nature Communications.

Downloads

Share

Further press releases

28th September 2026

Ceramides Drive Metastasis in Colorectal Cancer

Why do individual colorectal cancer cells form metastases? An international research team, including researchers from ISAS, has identified a mechanism whereby the body’s own synthesis of ceramides can promote the metastasis of colorectal cancer. The study also revealed the role played by the fat content of the diet. The researchers have now published the results of the preclinical model in Science.

Ceramides in colorectal tissue
13th July 2026

Fabry Disease: a Molecular Map of Lipids in Tissue

A new technique developed at ISAS combines Raman microscopy and mass spectrometry imaging, and it demonstrates that, for the first time, the spatial distribution of lipids can be visualised at cellular and subcellular levels – including further essential information. The new analytical method holds high potential for the diagnosis and treatment of conditions such as Fabry disease, in which molecules undergo local changes within the tissue.

2nd July 2026

Biomedical Image Analysis with AI

Dr Jianxu Chen is taking up a professorship in AI for Biomedical Analysis at the University of Duisburg-Essen. With his research group at ISAS, he is developing AI methods that can be used to comprehensively analyse enormous quantities of complex microscopy images.

Portrait von Dr. Jianxu Chen
29th June 2026

It's What's Inside That Counts: Neutrophils Form Distinct Subtypes

Neutrophils can be divided into two distinct subgroups with completely different functions. The surface protein CD177 plays a decisive role in this. For the first time, researchers from the Faculty of Medicine at the University of Duisburg-Essen and ISAS have been able to demonstrate, using a new integrated proteomics and lipidomics analysis, that the molecular signatures in CD177-defined neutrophils differ significantly from one another. The presence of this surface protein has implications for disease progression, for example in head and neck tumours.

CD177 negative Neutrophile
26th November 2025

New Drug Candidates for the Treatment of Heart Failure

Researchers from North Rhine-Westphalia are working on a new therapeutic approach for the treatment of heart failure as part of the recently launched HI-FIVE project. They are developing active substances that specifically inhibit an important enzyme with the aim of closing gaps in the care of patients with heart failure.

26th September 2025

Microbiome Research: EU Network METAMIC 3 Is Looking for Doctoral Candidates

In the new EU network METAMIC 3, young scientists will be researching the role of microbiomes in the context of ‘One Health’ for their dissertations. Metaproteomics methods will be applied in this research. Furthermore, stays at various European institutions are part of the doctoral programme. The doctoral positions are now open for applications.

Prof. Dr. Robert Heyer is Head of the research group Multidimensional Omics Data Analysis at ISAS and coordinator of the network.